{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T22:10:40Z","timestamp":1778278240880,"version":"3.51.4"},"reference-count":53,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Background and Objectives: The therapeutic role of surgery in Crohn\u2019s disease has evolved in the era of advanced biologic therapies, particularly in patients with complex and treatment-refractory disease. This study aimed to evaluate the relationship between preoperative biologic exposure and surgical outcomes, with a focus on predictors of more extensive surgical procedures, postoperative biological response, and postoperative biologic management. Materials and Methods: We conducted a retrospective cohort study including 60 patients with Crohn\u2019s disease who underwent CD-related surgical interventions between January 2011 and December 2024. Clinical, surgical, and therapeutic data were collected. Combined resection procedures were defined as intestinal resections associated with additional surgical interventions. Postoperative biological response was defined as an exploratory composite endpoint reflecting the simultaneous normalization of hemoglobin, serum albumin, and C-reactive protein at six months. Statistical analyses, including univariable and multivariable methods, were performed. Results: Combined resection procedures were associated with advanced disease, particularly penetrating phenotypes and intra-abdominal sepsis, and with more frequent postoperative biologic intensification (OR 5.56, 95% CI: 1.05\u201329.57, p = 0.044). Postoperative biologic management included maintenance and intensification strategies (initiation or switching of biologic therapy). At six months, postoperative biological response was achieved in 20.7% of patients (12\/58). No significant associations were observed between biological response and preoperative anti-TNF exposure or postoperative biologic intensification. Despite the relatively low rate of complete biological normalization, hemoglobin and albumin normalization were observed in 79.3% and 69.0% of patients, respectively, while the median fecal calprotectin decreased from 820 \u00b5g\/g preoperatively to 130 \u00b5g\/g at follow-up. Endoscopic remission was observed in 47.6% of patients with available SES-CD assessment. Conclusions: In patients with complex Crohn\u2019s disease, surgical intervention remains an essential component of multidisciplinary management. While complete postoperative biological normalization was achieved in a limited proportion of patients, surgery was associated with consistent improvements in inflammatory and nutritional parameters. Further prospective studies are needed to better define predictors of postoperative recovery and to clarify the role of surgery within modern treatment algorithms.<\/jats:p>","DOI":"10.3390\/medicina62050917","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T21:07:16Z","timestamp":1778274436000},"page":"917","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Biologic Therapy and Surgical Management in Crohn\u2019s Disease: Postoperative Outcomes and Biologic Management Patterns in a Retrospective Cohort Study"],"prefix":"10.3390","volume":"62","author":[{"given":"Constantin-Alexandru","family":"Petraru","sequence":"first","affiliation":[{"name":"Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tudor","family":"Stroie","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Gastroenterology, Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doina","family":"Istratescu","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Pitigoi","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corina Gabriela","family":"Meianu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Gastroenterology, Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0608-6565","authenticated-orcid":false,"given":"Rucsandra","family":"Ilinca-Diculescu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Gastroenterology, Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mircea","family":"Diculescu","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, \u201cCarol Davila\u201d University of Medicine and Pharmacy, 050474 Bucharest, Romania"},{"name":"Department of Gastroenterology, Fundeni Clinical Institute, 022328 Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1093\/ecco-jcc\/jjae091","article-title":"ECCO Guidelines on Therapeutics in Crohn\u2019s Disease: Medical Treatment","volume":"18","author":"Gordon","year":"2024","journal-title":"J. Crohns Colitis"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1093\/ecco-jcc\/jjae089","article-title":"ECCO Guidelines on Therapeutics in Crohn\u2019s Disease: Surgical Treatment","volume":"18","author":"Adamina","year":"2024","journal-title":"J. Crohns Colitis"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S2468-1253(17)30248-0","article-title":"Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn\u2019s disease: A randomised controlled, open-label, multicentre trial","volume":"2","author":"Ponsioen","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S2468-1253(25)00374-7","article-title":"Ileocaecal resection versus infliximab for ileal Crohn\u2019s disease: Retrospective 10-year follow-up of the LIR!C trial","volume":"11","author":"Oldenburg","year":"2026","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.dld.2025.07.009","article-title":"Long-term comparative outcomes after ileocecal resection for inflammatory versus complicated Crohn\u2019s disease: A multicenter, retrospective study (Crohn\u2019s-Urg)","volume":"57","author":"Avellaneda","year":"2025","journal-title":"Dig. Liver Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.26574\/maedica.2023.18.2.174","article-title":"Impact of dietary patterns in inflammatory bowel disease subtypes versus healthy subjects: A retrospective cohort study","volume":"18","author":"Preda","year":"2023","journal-title":"Maedica"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"717","DOI":"10.4240\/wjgs.v16.i3.717","article-title":"Predicting short-term major postoperative complications in intestinal resection for Crohn\u2019s disease: A machine learning-based study","volume":"16","author":"Wang","year":"2024","journal-title":"World J. Gastrointest. Surg."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJMoa1602773","article-title":"Ustekinumab as induction and maintenance therapy for Crohn\u2019s disease","volume":"375","author":"Feagan","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1016\/S0140-6736(22)00466-4","article-title":"Risankizumab as maintenance therapy for moderately to severely active Crohn\u2019s disease: Results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial","volume":"399","author":"Ferrante","year":"2022","journal-title":"Lancet"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1056\/NEJMoa2212728","article-title":"Upadacitinib induction and maintenance therapy for Crohn\u2019s disease","volume":"388","author":"Loftus","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1053\/j.gastro.2020.12.031","article-title":"STRIDE-II: An update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD (IOIBD): Determining therapeutic goals for treat-to-target strategies in IBD","volume":"160","author":"Turner","year":"2021","journal-title":"Gastroenterology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.14309\/ajg.0000000000003465","article-title":"ACG clinical guideline: Management of Crohn\u2019s disease in adults","volume":"120","author":"Lichtenstein","year":"2025","journal-title":"Am. J. Gastroenterol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1159\/000528070","article-title":"Significant differences in IBD care and education across Europe: Results of the pan-European VIPER survey","volume":"41","author":"Kral","year":"2023","journal-title":"Dig. Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"17562848231174290","DOI":"10.1177\/17562848231174290","article-title":"Barriers in inflammatory bowel disease care in Central and Eastern Europe: A region-specific analysis","volume":"16","author":"Lietava","year":"2023","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gut.2005.082909","article-title":"The Montreal classification of inflammatory bowel disease: Controversies, consensus, and implications","volume":"55","author":"Satsangi","year":"2006","journal-title":"Gut"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1093\/ecco-jcc\/jjz083","article-title":"Hypoalbuminaemia and postoperative outcomes in inflammatory bowel disease: The NSQIP surgical cohort","volume":"13","author":"Nguyen","year":"2019","journal-title":"J. Crohns Colitis"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Chen, R., Zheng, J., Li, C., Chen, Q., Zeng, Z., Li, L., Chen, M., and Zhang, S. (2023). Prognostic models for predicting postoperative recurrence in Crohn\u2019s disease: A systematic review and critical appraisal. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1215116"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1007\/s10620-019-5476-2","article-title":"Early postoperative anti-TNF therapy does not increase complications following abdominal surgery in Crohn\u2019s disease","volume":"64","author":"Schad","year":"2019","journal-title":"Dig. Dis. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(16)31711-1","article-title":"Crohn\u2019s disease","volume":"389","author":"Torres","year":"2017","journal-title":"Lancet"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/ecco-jcc\/jjw116","article-title":"Predicting outcomes to optimize disease management in inflammatory bowel diseases","volume":"10","author":"Torres","year":"2016","journal-title":"J. Crohns Colitis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ajg.2009.579","article-title":"The natural history of adult Crohn\u2019s disease in population-based cohorts","volume":"105","author":"Loftus","year":"2010","journal-title":"Am. J. Gastroenterol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Mignini, I., Blasi, V., Termite, F., Esposto, G., Borriello, R., Laterza, L., Scaldaferri, F., Ainora, M.E., Gasbarrini, A., and Zocco, M.A. (2024). Fibrostenosing Crohn\u2019s disease: Pathogenetic mechanisms and new therapeutic horizons. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25126326"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/2050640613487194","article-title":"Fistulizing Crohn\u2019s disease: Diagnosis and management","volume":"1","author":"Gecse","year":"2013","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.gastro.2016.09.047","article-title":"Mechanisms, management, and treatment of fibrosis in patients with inflammatory bowel diseases","volume":"152","author":"Rieder","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/00000658-200001000-00006","article-title":"Risk factors for surgery and postoperative recurrence in Crohn\u2019s disease","volume":"231","author":"Bernell","year":"2000","journal-title":"Ann. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/j.gastro.2013.07.041","article-title":"Risk of surgery for inflammatory bowel diseases has decreased over time: A systematic review and meta-analysis of population-based studies","volume":"145","author":"Frolkis","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000510999","article-title":"Abdominal surgery in Crohn\u2019s disease: Risk factors for complications","volume":"6","author":"Queiroz","year":"2021","journal-title":"Inflamm. Intest. Dis."},{"key":"ref_28","first-page":"1","article-title":"ECCO-ESCP consensus on surgery for Crohn\u2019s disease","volume":"12","author":"Bemelman","year":"2018","journal-title":"J. Crohns Colitis"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Hazel, K., and Cooney, R. (2025). Preoperative optimization for elective surgery in Crohn\u2019s disease: A narrative review. J. Clin. Med., 14.","DOI":"10.3390\/jcm14051576"},{"key":"ref_30","first-page":"10","article-title":"Perioperative optimization of Crohn\u2019s disease","volume":"6","author":"Lin","year":"2022","journal-title":"Ann. Gastroenterol. Surg."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-0036-1580633","article-title":"Perioperative considerations in Crohn disease and ulcerative colitis","volume":"29","author":"Nickerson","year":"2016","journal-title":"Clin. Colon Rectal Surg."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"102085","DOI":"10.1016\/j.gassur.2025.102085","article-title":"Comparative outcomes of laparoscopic and open surgery in inflammatory bowel disease in pediatric and young adult patients: A systematic review and meta-analysis","volume":"29","author":"Cassaro","year":"2025","journal-title":"J. Gastrointest. Surg."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ijsu.2020.05.064","article-title":"Preoperative hypoalbuminemia is an independent risk factor for postoperative complications in Crohn\u2019s disease patients with normal BMI: A cohort study","volume":"79","author":"Ge","year":"2020","journal-title":"Int. J. Surg."},{"key":"ref_34","first-page":"e57655","article-title":"Impact of preoperative serum albumin level on the outcome of colorectal cancer surgery","volume":"16","author":"Alajmi","year":"2024","journal-title":"Cureus"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s10151-020-02238-1","article-title":"Long-term healing after complex anal fistula repair in patients with Crohn\u2019s disease","volume":"24","author":"Mujukian","year":"2020","journal-title":"Tech. Coloproctol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/ueg2.12547","article-title":"Difficult-to-treat inflammatory bowel disease: Effectiveness and safety of 4th and 5th lines of treatment","volume":"12","author":"Caron","year":"2024","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000367859","article-title":"Abdominal abscess in Crohn\u2019s disease: Multidisciplinary management","volume":"32","author":"Carbonnel","year":"2014","journal-title":"Dig. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.MIB.0000173271.18319.53","article-title":"Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease","volume":"11","author":"Solem","year":"2005","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000527846","article-title":"Positioning and usefulness of biomarkers in inflammatory bowel disease","volume":"104","author":"Sakurai","year":"2023","journal-title":"Digestion"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1093\/ecco-jcc\/jjy195","article-title":"Diverting stoma for refractory ano-perineal Crohn\u2019s disease: Is it really useful in the anti-TNF era? A multivariate analysis in 74 consecutive patients","volume":"13","author":"Hain","year":"2019","journal-title":"J. Crohns Colitis"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1055\/s-0039-1683916","article-title":"Role of fecal diversion in complex Crohn\u2019s disease","volume":"32","author":"Burke","year":"2019","journal-title":"Clin. Colon Rectal Surg."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.3748\/wjg.v26.i42.6572","article-title":"Modern surgical strategies for perianal Crohn\u2019s disease","volume":"26","author":"Zabot","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"160","DOI":"10.5217\/ir.2017.15.2.160","article-title":"Preoperative use of anti-tumor necrosis factor therapy in Crohn\u2019s disease: Promises and pitfalls","volume":"15","author":"Kotze","year":"2017","journal-title":"Intest. Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.lers.2022.09.002","article-title":"What constitutes failure of medical therapy in the changing landscape of Crohn\u2019s disease?","volume":"5","author":"Huynh","year":"2022","journal-title":"Laparosc. Endosc. Robot. Surg."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s13304-021-01187-0","article-title":"Repeated surgery for recurrent Crohn\u2019s disease: Does the outcome keep worsening operation after operation? A comparative study of 1224 consecutive procedures","volume":"74","author":"Colombo","year":"2022","journal-title":"Updates Surg."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1093\/ibd\/izaa350","article-title":"Medical management following surgical therapy in inflammatory bowel disease: Evidence from Cochrane reviews","volume":"27","author":"Chande","year":"2021","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Aljabri, R., Al-Saraie, S., and Alhouti, A. (2025). Optimizing biologic therapy for the prevention of post-operative recurrence in Crohn\u2019s disease: Current evidence and future perspectives. Biomedicines, 13.","DOI":"10.20944\/preprints202503.0987.v1"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/ncp.10588","article-title":"The use of visceral proteins as nutrition markers: An ASPEN position paper","volume":"36","author":"Evans","year":"2021","journal-title":"Nutr. Clin. Pract."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/ibd\/izac054","article-title":"Prevalence, pathogenesis and management of anemia in inflammatory bowel disease: An IG-IBD multicenter, prospective, and observational study","volume":"29","author":"Bergamaschi","year":"2023","journal-title":"Inflamm. Bowel Dis."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1007\/s00384-019-03427-7","article-title":"High risk of septic complications following surgery for Crohn\u2019s disease in patients with preoperative anaemia, hypoalbuminemia and high CRP","volume":"34","author":"Ghoneima","year":"2019","journal-title":"Int. J. Color. Dis."},{"key":"ref_51","first-page":"e65868","article-title":"The role of minimally invasive surgery in the management of inflammatory bowel disease: Current trends and future directions","volume":"16","author":"Rathod","year":"2024","journal-title":"Cureus"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"17562848241251600","DOI":"10.1177\/17562848241251600","article-title":"Biomarkers in inflammatory bowel disease: A practical guide","volume":"17","author":"Clough","year":"2024","journal-title":"Ther. Adv. Gastroenterol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"508","DOI":"10.3748\/wjg.v29.i3.508","article-title":"Artificial intelligence and inflammatory bowel disease: Where are we going?","volume":"29","author":"Spadaccini","year":"2023","journal-title":"World J. Gastroenterol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/5\/917\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T21:17:47Z","timestamp":1778275067000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/62\/5\/917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":53,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["medicina62050917"],"URL":"https:\/\/doi.org\/10.3390\/medicina62050917","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]}}}